Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling

Li Zhang, Anand Singh, Christopher Plaisier, Nathanael Pruett, R. Taylor Ripley, David S. Schrump, Chuong D. Hoang

Research output: Contribution to journalArticle

Abstract

Therapies against malignant pleural mesothelioma (MPM) have yielded disappointing results, in part, because pathologic mechanisms remain obscure. In searching for rational molecular targets, we identified metadherin (MTDH), a multifunctional gene associated with several tumor types but previously unrecognized in MPM. Cox proportional hazards regression analysis delineated associations between higher MTDH expression and lower patient survival from three independent MPM cohorts (n = 349 patients). Through in vitro assays with overexpression and downregulation constructs in MPM cells, we characterized the role of MTDH. We confirmed in vivo the phenotype of altered MTDH expression in a murine xenograft model. Transcriptional regulators of MTDH were identified by chromatin immunoprecipitation. Overexpression of both MTDH mRNA (12-fold increased) and protein levels was observed in tumor tissues. MTDH stable overexpression significantly augmented proliferation, invasiveness, colony formation, chemoresistance, and an antiapoptosis phenotype, while its suppression showed opposite effects in MPM cells. Interestingly, NF-κB and c-Myc (in a feed-forward loop motif) contributed to modulating MTDH expression. Knockdown of MTDH expression profoundly retarded xenograft tumor growth. Thus, our findings support the notion that MTDH integrates upstream signals from certain transcription factors and mediates pathogenic interactions contributing to MPM traits. MTDH represents a new MPM-associated gene that can contribute to insights of MPM biology and, as such, suggest other treatment strategies.

Original languageEnglish (US)
Pages (from-to)859-870
Number of pages12
JournalTranslational Oncology
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Mesothelioma
Apoptosis
Heterografts
Phenotype
Neoplasms
Malignant Mesothelioma
Chromatin Immunoprecipitation
Genes
Transcription Factors
Down-Regulation
Regression Analysis
Messenger RNA
Survival
Therapeutics
Growth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling. / Zhang, Li; Singh, Anand; Plaisier, Christopher; Pruett, Nathanael; Ripley, R. Taylor; Schrump, David S.; Hoang, Chuong D.

In: Translational Oncology, Vol. 12, No. 6, 01.06.2019, p. 859-870.

Research output: Contribution to journalArticle

Zhang, Li ; Singh, Anand ; Plaisier, Christopher ; Pruett, Nathanael ; Ripley, R. Taylor ; Schrump, David S. ; Hoang, Chuong D. / Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling. In: Translational Oncology. 2019 ; Vol. 12, No. 6. pp. 859-870.
@article{08c3d30dbf5d4f9bb5d56007114af3b4,
title = "Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling",
abstract = "Therapies against malignant pleural mesothelioma (MPM) have yielded disappointing results, in part, because pathologic mechanisms remain obscure. In searching for rational molecular targets, we identified metadherin (MTDH), a multifunctional gene associated with several tumor types but previously unrecognized in MPM. Cox proportional hazards regression analysis delineated associations between higher MTDH expression and lower patient survival from three independent MPM cohorts (n = 349 patients). Through in vitro assays with overexpression and downregulation constructs in MPM cells, we characterized the role of MTDH. We confirmed in vivo the phenotype of altered MTDH expression in a murine xenograft model. Transcriptional regulators of MTDH were identified by chromatin immunoprecipitation. Overexpression of both MTDH mRNA (12-fold increased) and protein levels was observed in tumor tissues. MTDH stable overexpression significantly augmented proliferation, invasiveness, colony formation, chemoresistance, and an antiapoptosis phenotype, while its suppression showed opposite effects in MPM cells. Interestingly, NF-κB and c-Myc (in a feed-forward loop motif) contributed to modulating MTDH expression. Knockdown of MTDH expression profoundly retarded xenograft tumor growth. Thus, our findings support the notion that MTDH integrates upstream signals from certain transcription factors and mediates pathogenic interactions contributing to MPM traits. MTDH represents a new MPM-associated gene that can contribute to insights of MPM biology and, as such, suggest other treatment strategies.",
author = "Li Zhang and Anand Singh and Christopher Plaisier and Nathanael Pruett and Ripley, {R. Taylor} and Schrump, {David S.} and Hoang, {Chuong D.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.tranon.2019.03.005",
language = "English (US)",
volume = "12",
pages = "859--870",
journal = "Translational Oncology",
issn = "1936-5233",
publisher = "Neoplasia Press",
number = "6",

}

TY - JOUR

T1 - Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling

AU - Zhang, Li

AU - Singh, Anand

AU - Plaisier, Christopher

AU - Pruett, Nathanael

AU - Ripley, R. Taylor

AU - Schrump, David S.

AU - Hoang, Chuong D.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Therapies against malignant pleural mesothelioma (MPM) have yielded disappointing results, in part, because pathologic mechanisms remain obscure. In searching for rational molecular targets, we identified metadherin (MTDH), a multifunctional gene associated with several tumor types but previously unrecognized in MPM. Cox proportional hazards regression analysis delineated associations between higher MTDH expression and lower patient survival from three independent MPM cohorts (n = 349 patients). Through in vitro assays with overexpression and downregulation constructs in MPM cells, we characterized the role of MTDH. We confirmed in vivo the phenotype of altered MTDH expression in a murine xenograft model. Transcriptional regulators of MTDH were identified by chromatin immunoprecipitation. Overexpression of both MTDH mRNA (12-fold increased) and protein levels was observed in tumor tissues. MTDH stable overexpression significantly augmented proliferation, invasiveness, colony formation, chemoresistance, and an antiapoptosis phenotype, while its suppression showed opposite effects in MPM cells. Interestingly, NF-κB and c-Myc (in a feed-forward loop motif) contributed to modulating MTDH expression. Knockdown of MTDH expression profoundly retarded xenograft tumor growth. Thus, our findings support the notion that MTDH integrates upstream signals from certain transcription factors and mediates pathogenic interactions contributing to MPM traits. MTDH represents a new MPM-associated gene that can contribute to insights of MPM biology and, as such, suggest other treatment strategies.

AB - Therapies against malignant pleural mesothelioma (MPM) have yielded disappointing results, in part, because pathologic mechanisms remain obscure. In searching for rational molecular targets, we identified metadherin (MTDH), a multifunctional gene associated with several tumor types but previously unrecognized in MPM. Cox proportional hazards regression analysis delineated associations between higher MTDH expression and lower patient survival from three independent MPM cohorts (n = 349 patients). Through in vitro assays with overexpression and downregulation constructs in MPM cells, we characterized the role of MTDH. We confirmed in vivo the phenotype of altered MTDH expression in a murine xenograft model. Transcriptional regulators of MTDH were identified by chromatin immunoprecipitation. Overexpression of both MTDH mRNA (12-fold increased) and protein levels was observed in tumor tissues. MTDH stable overexpression significantly augmented proliferation, invasiveness, colony formation, chemoresistance, and an antiapoptosis phenotype, while its suppression showed opposite effects in MPM cells. Interestingly, NF-κB and c-Myc (in a feed-forward loop motif) contributed to modulating MTDH expression. Knockdown of MTDH expression profoundly retarded xenograft tumor growth. Thus, our findings support the notion that MTDH integrates upstream signals from certain transcription factors and mediates pathogenic interactions contributing to MPM traits. MTDH represents a new MPM-associated gene that can contribute to insights of MPM biology and, as such, suggest other treatment strategies.

UR - http://www.scopus.com/inward/record.url?scp=85064921322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064921322&partnerID=8YFLogxK

U2 - 10.1016/j.tranon.2019.03.005

DO - 10.1016/j.tranon.2019.03.005

M3 - Article

VL - 12

SP - 859

EP - 870

JO - Translational Oncology

JF - Translational Oncology

SN - 1936-5233

IS - 6

ER -